Bacterial effectors targeting the IKK/NF-kB pathway
Bacterial effectors targeting the IKK/NF-kB pathway
批准号:
8495491
负责人:
Philip Ross Hardwidge
金额:
$8.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-01-11 至 2017-12-31
关键词:
Animal ModelBacteriaBacterial InfectionsBiochemicalCellsChimeric ProteinsCitrobacterCitrobacter rodentiumComplexDataDiarrheaDiseaseDisease OutbreaksEscherichia coliEscherichia coli EHECFoodGenetic TranscriptionGoalsHealthHost DefenseHumanImmune Response GenesImmune responseImmune systemImmunityInfectionInflammatoryInflammatory ResponseLipopolysaccharidesMeatMolecularMusMutationNF-kappa BNamesNatural ImmunityNuclearNuclear ImportNuclear TranslocationPathway interactionsPhosphorylationPhosphotransferasesPlayProcessProtein KinaseProteinsQualifyingResearchRibosomal ProteinsRoleSalmonellaSeriesSerotypingShigellaSignal TransductionSignal Transduction PathwaySubstrate SpecificitySystemTestingType III Secretion System PathwayVegetablesVirulenceVirulentWaterWater PollutionWild Type MouseWorkYersiniaenteric pathogenfoodborne outbreakimprovedinhibitor/antagonistinnovationnovelpathogenpreventpromoterpublic health relevanceresearch studyresponseribosomal protein S3spatiotemporalsuccesstranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Despite costly attempts to reduce bacterial contamination of water, meat, and vegetables, Shiga toxin- producing E. coli (STEC) and related enteric pathogens (e.g. Salmonella, Shigella, Yersinia) are causing increasingly frequent outbreaks of food-borne diarrheal disease, thus constituting enormous health burdens. These pathogens use a type III secretion system (T3SS) to inject virulence proteins (effectors) into host cells. While T3SS effectors clearly play essential roles in bacterial virulence, the mechanisms by which they subvert the functions of host cells to promote pathogen survival are incompletely characterized. We are studying the mammalian signal transduction pathways targeted by STEC effectors, with the ultimate goal of improving our ability to prevent and to treat
bacterial infections. We have made the important and unique discovery that the STEC strains associated with severe diarrheal disease outbreaks in humans express a pair of homologous effectors that differentially regulate host innate immunity by disrupting the transcriptional responses to infection that are normally coordinated by the NF-kB pathway. NF-kB activity at key innate immune response genes is regulated by ribosomal protein S3 (RPS3), which possesses an accessory nuclear function as an NF-kB subunit. We discovered that the NleH1 effector protein inhibits RPS3 nuclear translocation, reducing NF-kB activity at specific promoters. Specifically, NleH1 inhibits the Ik¿ kinase complex (IKK¿) from phosphorylating RPS3, a critical requirement for its nuclear translocation. STEC strains also encode a homologous effector named NleH2. Despite sharing 84 % identity with NleH1, NleH2 stimulates rather than inhibits RPS3/NF-kB-dependent transcription. We hypothesize that the NleH1 and NleH2 effectors promote bacterial virulence by subverting the pro- inflammatory responses to infection normally regulated by RPS3/NF-kB and propose the following specific aims: 1) Quantify the importance of NleH effectors to bacterial virulence using animal models of diarrheal disease. 2) Characterize the molecular mechanism by which NleH1 inhibits IKK¿ phosphorylation of RPS3 to prevent its nuclear import. 3) Elucidate mechanistic differences between NleH1 and NleH2 and their pathophysiological significance in regulating RPS3/NF-kB-dependent signaling. Successful completion of the proposed research will 1) reveal how these bacterial effectors selectively modulate innate immunity; 2) clarify how pathogens have evolved to co-opt the accessory nuclear functions of ribosomal proteins; and 3) characterize how bacteria have integrated their virulence proteins into host signal transduction pathways in specific spatiotemporal contexts.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
T3SS Effector Regulation of Bacterial Metabolism
-
批准号:10425770
-
项目类别:
-
资助金额:$18.65万
-
财政年份:2022
-
负责人:Philip Ross Hardwidge
-
依托单位:
Molecular and Cellular Biology Core
-
批准号:10642676
-
项目类别:
-
资助金额:$34.11万
-
财政年份:2020
-
负责人:Philip Ross Hardwidge
-
依托单位:
Molecular and Cellular Biology Core
-
批准号:10397674
-
项目类别:
-
资助金额:$27.06万
-
财政年份:2020
-
负责人:Philip Ross Hardwidge
-
依托单位:
Functions of Translocated Bacterial Glycosyltransferases
-
批准号:9222103
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2016
-
负责人:Philip Ross Hardwidge
-
依托单位:
An enterotoxigenic E. coli protein that antagonizes the NF-kappaB pathway
-
批准号:8891351
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2014
-
负责人:Philip Ross Hardwidge
-
依托单位:
Bacterial effectors targeting the IKK/NF-kB pathway
-
批准号:8791592
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2013
-
负责人:Philip Ross Hardwidge
-
依托单位:
Bacterial effectors targeting the IKK/NF-kB pathway
-
批准号:9188797
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2013
-
负责人:Philip Ross Hardwidge
-
依托单位:
Reverse vaccinology of enterotoxigenic E. coli
-
批准号:8518225
-
项目类别:
-
资助金额:$21.15万
-
财政年份:2012
-
负责人:Philip Ross Hardwidge
-
依托单位:
Bacterial effectors targeting the IKK/NF-kB pathway
-
批准号:8589734
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2012
-
负责人:Philip Ross Hardwidge
-
依托单位:
Reverse vaccinology of enterotoxigenic E. coli
-
批准号:8589931
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2012
-
负责人:Philip Ross Hardwidge
-
依托单位:
Delivery of a bacterial inhibitor of NF-kB to colon tumors
-
批准号:8296462
-
项目类别:
-
资助金额:$0.83万
-
财政年份:2011
-
负责人:Philip Ross Hardwidge
-
依托单位:
Bacterial effector inhibition of type I interferon
-
批准号:8227954
-
项目类别:
-
资助金额:$2.9万
-
财政年份:2011
-
负责人:Philip Ross Hardwidge
-
依托单位:
Delivery of a bacterial inhibitor of NF-kB to colon tumors
-
批准号:8636895
-
项目类别:
-
资助金额:$6.67万
-
财政年份:2011
-
负责人:Philip Ross Hardwidge
-
依托单位:
Bacterial effector inhibition of type I interferon
-
批准号:8609163
-
项目类别:
-
资助金额:$15.85万
-
财政年份:2011
-
负责人:Philip Ross Hardwidge
-
依托单位:
Delivery of a bacterial inhibitor of NF-kB to colon tumors
-
批准号:8184998
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2011
-
负责人:Philip Ross Hardwidge
-
依托单位:
Bacterial effector inhibition of type I interferon
-
批准号:8088850
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2011
-
负责人:Philip Ross Hardwidge
-
依托单位:
Bacterial effector subversion of host protein trafficking
-
批准号:7862895
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2010
-
负责人:Philip Ross Hardwidge
-
依托单位:
Disruption of NF-kB signaling by diarrheagenic Escherichia coli
-
批准号:8129920
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2010
-
负责人:Philip Ross Hardwidge
-
依托单位:
Bacterial effector subversion of host protein trafficking
-
批准号:8019137
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2010
-
负责人:Philip Ross Hardwidge
-
依托单位:
MODULATION OF NF-KB SIGNALLING BY E COLI PROTEIN KINASES
-
批准号:8168402
-
项目类别:
-
资助金额:$26.93万
-
财政年份:2010
-
负责人:Philip Ross Hardwidge
-
依托单位:
国内基金
海外基金
Segmented Filamentous Bacteria激活宿主免疫系统抑制其拮抗菌 Enterobacteriaceae维持菌群平衡及其机制研究
-
批准号:81971557
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2019
-
负责人:毛开睿
-
依托单位:
电缆细菌(Cable bacteria)对水体沉积物有机污染的响应与调控机制
-
批准号:51678163
-
项目类别:面上项目
-
资助金额:64.0万元
-
批准年份:2016
-
负责人:许玫英
-
依托单位: